🔎 Trials Near Me

Pradžia › Aterosklerozė › New Jersey

Aterosklerozė klinikiniai tyrimai New Jersey

6 tyrimai dėl Aterosklerozė ieško dalyvių vietose New Jersey.

Miestai New Jersey

Oficialus tyrimo tekstas (anglų kalba)

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

  • Clinical Research of Philadelphia, Pennington
  • Cardio Metabolic Institute, Somerset
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • CardioMetabolic Collaborative Clinic, Somerset
Renkami dalyviai3 fazė
Amžius nuo 45 iki 99 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Hypertension & Nephrology Association, Eatontown
  • New Jersey Kidney Care, Jersey City
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Bridgewater
  • Research Site, Elmer
  • Research Site, Haddon Heights
  • ir dar 2
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-24 · NCT07000357

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

  • Overlook Medical Center, Summit
Renkami dalyviai3 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-08-07 · NCT06813911

Pelacarsen Roll-over Extension Program

  • Robert Wood Johnson Medical School, New Brunswick
  • Overlook Medical Center, Summit
Renkami dalyviai3 fazė
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-07-29 · NCT06875973

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.